SEC Form 4 · accession 0001127602-18-026852
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M. Huff Gary
Officer — CEO, LabCorp Diagnostics
Period of report
Sep 4, 2018
Accepted (ET)
Sep 6, 2018 · 10:21 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 4, 2018 | M | 153 | — | A | 1,919 | D | |
| Common StockF2 | Sep 4, 2018 | F | 69 | $169.15 | D | 1,850 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF5,F1,F4 | — | Sep 4, 2018 | M | 153 | D | — | — | Common Stock | 153 | 11,068 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- F2Amount includes 155.2506 shares acquired on June 29, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
- F3Stock withholding to satisfy tax withholding obligations.
- F4The Restricted Stock Units vest in three equal annual installments beginning on 9/1/17.
- F5This number reflects the aggregate number of Restricted Stock Units held by the reporting person.